108 related articles for article (PubMed ID: 28035058)
1. MRTF-A can activate Nrf2 to increase the resistance to doxorubicin.
Xu Y; Luo Y; Wang ZY; Li X; Zheng P; Zhang TC
Oncotarget; 2017 Jan; 8(5):8436-8446. PubMed ID: 28035058
[TBL] [Abstract][Full Text] [Related]
2. Transcription of HOTAIR is regulated by RhoC-MRTF-A-SRF signaling pathway in human breast cancer cells.
He H; Wei Z; Du F; Meng C; Zheng D; Lai Y; Yao H; Zhou H; Wang N; Luo XG; Ma W; Zhang TC
Cell Signal; 2017 Feb; 31():87-95. PubMed ID: 28069441
[TBL] [Abstract][Full Text] [Related]
3. Myocardin-related transcription factor A (MRTF-A) mediates doxorubicin-induced PERP transcription in colon cancer cells.
Chen B; Li Z; Feng Y; Wu X; Xu Y
Biochem Biophys Res Commun; 2018 Sep; 503(3):1732-1739. PubMed ID: 30078679
[TBL] [Abstract][Full Text] [Related]
4. Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells.
Chen HH; Chang HH; Chang JY; Tang YC; Cheng YC; Lin LM; Cheng SY; Huang CH; Sun MW; Chen CT; Kuo CC
Free Radic Biol Med; 2017 Dec; 113():505-518. PubMed ID: 29080842
[TBL] [Abstract][Full Text] [Related]
5. Drug resistance associates with activation of Nrf2 in MCF-7/DOX cells, and wogonin reverses it by down-regulating Nrf2-mediated cellular defense response.
Zhong Y; Zhang F; Sun Z; Zhou W; Li ZY; You QD; Guo QL; Hu R
Mol Carcinog; 2013 Oct; 52(10):824-34. PubMed ID: 22593043
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidate signaling stabilizes Nrf2 and increases the expression of genes involved in drug resistance and oxidative stress responses: implications for cancer treatment.
Venkatraman G; Benesch MG; Tang X; Dewald J; McMullen TP; Brindley DN
FASEB J; 2015 Mar; 29(3):772-85. PubMed ID: 25398768
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway.
Shim GS; Manandhar S; Shin DH; Kim TH; Kwak MK
Free Radic Biol Med; 2009 Dec; 47(11):1619-31. PubMed ID: 19751820
[TBL] [Abstract][Full Text] [Related]
8. NRF2/ABCB1-mediated efflux and PARP1-mediated dampening of DNA damage contribute to doxorubicin resistance in chronic hypoxic HepG2 cells.
Xia X; Wang Q; Ye T; Liu Y; Liu D; Song S; Zheng C
Fundam Clin Pharmacol; 2020 Feb; 34(1):41-50. PubMed ID: 31420991
[TBL] [Abstract][Full Text] [Related]
9. The role of myocardin-related transcription factor-A in Aβ25-35 induced neuron apoptosis and synapse injury.
Zhang Y; Pan HY; Hu XM; Cao XL; Wang J; Min ZL; Xu SQ; Xiao W; Yuan Q; Li N; Cheng J; Zhao SQ; Hong X
Brain Res; 2016 Oct; 1648(Pt A):27-34. PubMed ID: 27387387
[TBL] [Abstract][Full Text] [Related]
10. MRTF/SRF dependent transcriptional regulation of TAZ in breast cancer cells.
Liu CY; Chan SW; Guo F; Toloczko A; Cui L; Hong W
Oncotarget; 2016 Mar; 7(12):13706-16. PubMed ID: 26885614
[TBL] [Abstract][Full Text] [Related]
11. Histone acetyltransferase p300 promotes MRTF-A-mediates transactivation of VE-cadherin gene in human umbilical vein endothelial cells.
Shu XZ; Zhang LN; Zhang R; Zhang CJ; He HP; Zhou H; Wang N; Zhang TC
Gene; 2015 May; 563(1):17-23. PubMed ID: 25746323
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin inhibits nuclear accumulation of Nrf2: implications for chemoresistance of cancer cells.
Kim WD; Kim YW; Cho IJ; Lee CH; Kim SG
J Cell Sci; 2012 Mar; 125(Pt 5):1284-95. PubMed ID: 22302998
[TBL] [Abstract][Full Text] [Related]
13. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.
Chian S; Li YY; Wang XJ; Tang XW
Asian Pac J Cancer Prev; 2014; 15(6):2911-6. PubMed ID: 24761924
[TBL] [Abstract][Full Text] [Related]
14. HER2 confers drug resistance of human breast cancer cells through activation of NRF2 by direct interaction.
Kang HJ; Yi YW; Hong YB; Kim HJ; Jang YJ; Seong YS; Bae I
Sci Rep; 2014 Dec; 4():7201. PubMed ID: 25467193
[TBL] [Abstract][Full Text] [Related]
15. MiR-141 Activates Nrf2-Dependent Antioxidant Pathway via Down-Regulating the Expression of Keap1 Conferring the Resistance of Hepatocellular Carcinoma Cells to 5-Fluorouracil.
Shi L; Wu L; Chen Z; Yang J; Chen X; Yu F; Zheng F; Lin X
Cell Physiol Biochem; 2015; 35(6):2333-48. PubMed ID: 25896253
[TBL] [Abstract][Full Text] [Related]
16. Apigenin sensitizes doxorubicin-resistant hepatocellular carcinoma BEL-7402/ADM cells to doxorubicin via inhibiting PI3K/Akt/Nrf2 pathway.
Gao AM; Ke ZP; Wang JN; Yang JY; Chen SY; Chen H
Carcinogenesis; 2013 Aug; 34(8):1806-14. PubMed ID: 23563091
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway.
Chi HC; Chen SL; Cheng YH; Lin TK; Tsai CY; Tsai MM; Lin YH; Huang YH; Lin KH
Cell Death Dis; 2016 Aug; 7(8):e2324. PubMed ID: 27490929
[TBL] [Abstract][Full Text] [Related]
18. Mutant p53 confers chemoresistance in non-small cell lung cancer by upregulating Nrf2.
Tung MC; Lin PL; Wang YC; He TY; Lee MC; Yeh SD; Chen CY; Lee H
Oncotarget; 2015 Dec; 6(39):41692-705. PubMed ID: 26497680
[TBL] [Abstract][Full Text] [Related]
19. Cancer Cell Growth Is Differentially Affected by Constitutive Activation of NRF2 by KEAP1 Deletion and Pharmacological Activation of NRF2 by the Synthetic Triterpenoid, RTA 405.
Probst BL; McCauley L; Trevino I; Wigley WC; Ferguson DA
PLoS One; 2015; 10(8):e0135257. PubMed ID: 26301506
[TBL] [Abstract][Full Text] [Related]
20. Nrf2 protein up-regulates antiapoptotic protein Bcl-2 and prevents cellular apoptosis.
Niture SK; Jaiswal AK
J Biol Chem; 2012 Mar; 287(13):9873-9886. PubMed ID: 22275372
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
